Literature DB >> 6340494

Disparate cardiovascular effects of obesity and arterial hypertension.

F H Messerli, K Sundgaard-Riise, E Reisin, G Dreslinski, F G Dunn, E Frohlich.   

Abstract

Since obesity and essential hypertension frequently coexist, a study was designed to analyze some of their cardiovascular effects. Twenty-eight obese patients, half of whom were normotensive and half with established hypertension, were matched for mean arterial pressure with 28 corresponding lean subjects. Systemic and renal hemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels were measured. Obese patients had increased cardiac output (p less than 0.001), stroke volume (p less than 0.001), central blood volume (p less than 0.02), plasma and total blood volume (p less than 0.01), and decreased total peripheral resistance (p less than 0.001). In contrast, cardiac output, central blood volume, and stroke volume of hypertensive patients were normal, but they had increased total peripheral (p less than 0.001) and renal vascular resistance (p less than 0.001) and a contracted intravascular volume. Left ventricular stroke work was elevated to a similar level in obesity (p less than 0.001) and hypertension (p less than 0.02), but the increase was caused by an expanded stroke volume in the former and by an increase in systolic pressure in the latter. It is concluded that the disparate effects of obesity and hypertension on total peripheral resistance and intravascular volume counteract and may even offset each other. Thus, obesity may mitigate the effects of chronically elevated total peripheral resistance (and therefore end-organ damage) in essential hypertension. Since both entities affect the heart through different mechanisms, their presence in the same patient results in a double burden to the left ventricle, thereby gently enhancing the long-term risk of congestive failure.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6340494     DOI: 10.1016/0002-9343(83)91071-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  33 in total

1.  Are people with normal radionuclide perfusion imaging studies better-off if they are obese?

Authors:  Farbod Raiszadeh; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2010-06       Impact factor: 5.952

2.  Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention.

Authors:  Gjin Ndrepepa; Dritan Keta; Robert A Byrne; Stefanie Schulz; Julinda Mehilli; Melchior Seyfarth; Albert Schömig; Adnan Kastrati
Journal:  Heart Vessels       Date:  2010-01-21       Impact factor: 2.037

3.  Correlates of Segmental Pulse Wave Velocity in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Michelle L Meyer; Hirofumi Tanaka; Priya Palta; Susan Cheng; Natalia Gouskova; David Aguilar; Gerardo Heiss
Journal:  Am J Hypertens       Date:  2015-06-04       Impact factor: 2.689

Review 4.  Stress and salt sensitivity in primary hypertension.

Authors:  Deborah L Stewart; Gregory A Harshfield; Haidong Zhu; Coral D Hanevold
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 5.  Vasodilator signals from perivascular adipose tissue.

Authors:  Maik Gollasch
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

6.  Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers.

Authors:  Margreke J E Brill; Anne van Rongen; Aletta P I Houwink; Jacobus Burggraaf; Bert van Ramshorst; René J Wiezer; Eric P A van Dongen; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

7.  Effects of isolated obesity on systolic and diastolic left ventricular function.

Authors:  M Pascual; D A Pascual; F Soria; T Vicente; A M Hernández; F J Tébar; M Valdés
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

Review 8.  Neural mechanisms and management of obesity-related hypertension.

Authors:  Murray D Esler; Nina Eikelis; Elisabeth Lambert; Nora Straznicky
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

9.  Obesity as a determinant for response to antihypertensive treatment.

Authors:  R E Schmieder; C Gatzka; H Schächinger; H Schobel; H Rüddel
Journal:  BMJ       Date:  1993-08-28

10.  Interactions between insulin and norepinephrine on blood pressure and insulin sensitivity. Studies in lean and obese men.

Authors:  A D Baron; G Brechtel; A Johnson; N Fineberg; D P Henry; H O Steinberg
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.